Distribution of microRNA biomarker candidates in solid tissues and body fluids
暂无分享,去创建一个
[1] J. Mariani,et al. The transcardiac gradient of cardio‐microRNAs in the failing heart , 2016, European journal of heart failure.
[2] Xin Li,et al. Decreased expression of microRNA-320a promotes proliferation and invasion of non-small cell lung cancer cells by increasing VDAC1 expression , 2016, Oncotarget.
[3] Yu Yang,et al. MicroRNA-320a promotes 5-FU resistance in human pancreatic cancer cells , 2016, Scientific Reports.
[4] Y. Kakimoto,et al. MicroRNA deep sequencing reveals chamber-specific miR-208 family expression patterns in the human heart. , 2016, International journal of cardiology.
[5] R. Gambari,et al. Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: New trends in the development of miRNA therapeutic strategies in oncology (Review) , 2016, International journal of oncology.
[6] A. Orekhov,et al. Cardiac-specific miRNA in cardiogenesis, heart function, and cardiac pathology (with focus on myocardial infarction). , 2016, Journal of molecular and cellular cardiology.
[7] Ying Wang,et al. MiR-320a inhibits gastric carcinoma by targeting activity in the FoxM1-P27KIP1 axis , 2016, Oncotarget.
[8] Eckart Meese,et al. Can circulating miRNAs live up to the promise of being minimal invasive biomarkers in clinical settings? , 2016, Wiley interdisciplinary reviews. RNA.
[9] A. Keller,et al. Distribution of miRNA expression across human tissues , 2016, Nucleic acids research.
[10] Christina Backes,et al. Bias in High-Throughput Analysis of miRNAs and Implications for Biomarker Studies. , 2016, Analytical chemistry.
[11] Christina Backes,et al. High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer , 2015, Oncotarget.
[12] Christina Backes,et al. Towards Clinical Applications of Blood-Borne miRNA Signatures: The Influence of the Anticoagulant EDTA on miRNA Abundance , 2015, PloS one.
[13] S. Rome,et al. Diagnostic Value of Cell-free Circulating MicroRNAs for Obesity and Type 2 Diabetes: A Meta-analysis. , 2015, Journal of molecular biomarkers & diagnosis.
[14] P. Raggi,et al. Utility of Select Plasma MicroRNA for Disease and Cardiovascular Risk Assessment in Patients with Rheumatoid Arthritis , 2015, The Journal of Rheumatology.
[15] H. Bannasch,et al. Identification of a blood-borne miRNA signature of synovial sarcoma , 2015, Molecular Cancer.
[16] Hans-Peter Lenhof,et al. Circulating serum miRNAs as potential biomarkers for nephroblastoma , 2015, Pediatric blood & cancer.
[17] Terrence S. Furey,et al. MicroRNAs Classify Different Disease Behavior Phenotypes of Crohn's Disease and May Have Prognostic Utility , 2015, Inflammatory bowel diseases.
[18] Christina Backes,et al. Longitudinal study on circulating miRNAs in patients after lung cancer resection , 2015, Oncotarget.
[19] A. Keller,et al. The blood-borne miRNA signature of lung cancer patients is independent of histology but influenced by metastases , 2014, Molecular Cancer.
[20] A. Keller,et al. The human miRNA repertoire of different blood compounds , 2014, BMC Genomics.
[21] C. Sander,et al. A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing , 2007, Cell.